Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Oncology Nutrition Market

Oncology Nutrition Market Trends

Report ID: GMI9015
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Oncology Nutrition Market Trends

The rising prevalence of cancer worldwide is a significant driver for the market. As the number of cancer patients increases, the demand for specialized nutrition products and services tailored to meet the nutritional needs of cancer patients rises. For instance, as per the report published by World Health Organization in July 2023 breast cancer and lung cancer is among the leading cause of cancer-related deaths worldwide. Also, the report stated that, more than 1.9 million new cases of colorectal cancer and more than 930 000 deaths due to colorectal cancer were estimated to have occurred worldwide. Therefore, such a rapid rise in the prevalence of cancer will increase the early cancer diagnostic and treatment along with nutritional care, thereby propelling the market growth.
Moreover, cancer patients often experience malnutrition due to various factors such as reduced appetite, side effects of treatment, metabolic changes, and the presence of the tumor. Thus, proper nutrition plays a crucial role in managing cancer-related malnutrition, supporting the immune system, and improving treatment outcomes.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oncology nutrition industry size recorded USD 2.1 billion in 2023 and is expected to register 8.1% CAGR from 2024 to 2032, due to the rising global prevalence of cancer.

The stomach and gastrointestinal cancer segment in the market accounted for USD 472 million in revenue in 2023, owing to poor dietary habits like high consumption of processed foods, red meats, and low intake of fruits and vegetables.

North America oncology nutrition industry held 42.7% revenue share in 2023 and is expected to depict substantial growth from 2024 to 2032, led by the increasing prevalence of cancer and the growing number of cancer survivors.

Abbott Laboratories, Baxter International Inc., B. Braun Melsungen AG, Danone (Nutricia), Fresenius SE & Co. KGaA, Grifol S.A., Hormel Foods Corporation, Meiji Holdings Co., Ltd., Medtrition Inc., Nestle S.A., and Victus, Inc. are some of the major oncology nutrition companies worldwide.